Mammoth de-extinction becomes a $10B biz as gene editing gets buzzy
5mins read: A Daily Newsletter (No Politics)
Hey Small Biters,
Mammoth de-extinction becomes a $10B biz as gene editing gets buzzy
Innovative Ambition: Colossal Biosciences has raised $200 million in Series B funding, bringing its valuation to $1.2 billion. The company is focused on de-extinction projects, with plans to bring back the woolly mammoth and other species.
Applications Beyond Mammoths: Th…
Keep reading with a 7-day free trial
Subscribe to Small Bites to keep reading this post and get 7 days of free access to the full post archives.